LIMN (STOCKS)

    Liminatus Pharma, Inc. Class A Common Stock

    $0.710000
    -0.550000 (-43.65%)
    Prev close: $1.260000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Pharmaceuticals: Major
    CEO
    Chris Kim
    Asset Type
    stocks
    Website
    Fundamentals
    Market Cap
    $16.19M
    Employees
    3
    P/E (TTM)
    -3.22
    P/B (TTM)
    -9.82
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State
    Recent News

    No recent news found for this ticker.

    Financial Statements
    TTM (Sep 2025)
    Assets $1.34M
    Current Assets $1.20M
    Noncurrent Assets $139.04K
    Fixed Assets $12.76K
    Other Non-current Assets $126.28K
    Liabilities $2.99M
    Current Liabilities $2.86M
    Noncurrent Liabilities $123.58K
    Equity -$1.65M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent -$1.65M
    Liabilities And Equity $1.34M